Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Tele-assessment and Face-to-face Assessment of the 30-second Sit-stand Test in Peripheral Artery Disease

Consistency Between Tele-Assessment and Face-to-Face Assessment Results of the 30-Second Sit-to-Stand Test in Patients With Peripheral Arterial Disease

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Peripheral artery disease (PAD) is a chronic and progressive condition caused by narrowing or blockage of arteries in the lower limbs due to atherosclerosis. It primarily affects adults over 50, with prevalence increasing with age, and its clinical presentation ranges from asymptomatic cases to severe ischemia that may require amputation. Intermittent claudication, characterized by exercise-induced leg pain that resolves with rest, is the most common early symptom. Impaired blood flow, poor vascularization, and muscle loss contribute to reduced lower limb strength and functional capacity, which are associated with higher morbidity and mortality. Walking exercises is a cornerstone of PAD management, particularly for patients with no or mild symptoms, making the assessment of lower limb strength and mobility essential for designing rehabilitation programs. The 30-second sit-to-stand test is a validated and practical measure of functional capacity and walking ability. Tele-assessment using video technology has been shown to be feasible and reliable in other patient populations. Although tele-rehabilitation has been widely studied and shown to improve functional outcomes, research on tele-assessment methods to accurately evaluate patient performance and the effectiveness of rehabilitation programs is still limited, particularly in PAD patients. This study aims to examine the reliability of the 30-second sit-to-stand test when performed via tele-assessment compared with face-to-face evaluation in patients with PAD.

Who May Be Eligible (Plain English)

Who May Qualify: - Aged between 18 and 65 years - Diagnosed with peripheral artery disease, Fontaine stage I-II, confirmed by peripheral angiography or Doppler ultrasonography - Willingness to participate in the study - Access to a smartphone and the internet Who Should NOT Join This Trial: - Presence of orthopedic, neurological, or psychological conditions that limit physical activity - Neurological or musculoskeletal disorders affecting standing or walking - History of ischemic amputation - Acute inflammatory condition - Use of walking aids - Visual or hearing impairment - Vestibular system disorder - Cognitive impairment affecting cooperation - Severe cardiopulmonary diseases limiting walking ability - Major surgery or myocardial infarction within the last three months - Unstable coronary artery disease Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Aged between 18 and 65 years * Diagnosed with peripheral artery disease, Fontaine stage I-II, confirmed by peripheral angiography or Doppler ultrasonography * Willingness to participate in the study * Access to a smartphone and the internet Exclusion Criteria: * Presence of orthopedic, neurological, or psychological conditions that limit physical activity * Neurological or musculoskeletal disorders affecting standing or walking * History of ischemic amputation * Acute inflammatory condition * Use of walking aids * Visual or hearing impairment * Vestibular system disorder * Cognitive impairment affecting cooperation * Severe cardiopulmonary diseases limiting walking ability * Major surgery or myocardial infarction within the last three months * Unstable coronary artery disease

Locations (1)

Dokuz Eylul University Faculty of Medicine
Izmir, Balçova, Turkey (Türkiye)